Royal Bank Of Canada Renovacor, Inc. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.12 - $2.18 $20 - $372	171 New	171 $0
Q2 2022 Aug 15, 2022	SELL	$1.56 - $4.29 $312 - $858	-200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.73 - $10.65 $1,546 - $2,130	200 New	200 $2,000

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.